Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
Public ClinicalTrials.gov record NCT02847559. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Single Arm, Multi-center, Open Label Trial Combining Optune With Concurrent Bevacizumab in the Setting of Recurrent or Progressive Meningioma
Study identification
- NCT ID
- NCT02847559
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Northwestern University
- Other
- Enrollment
- 27 participants
Conditions and interventions
Conditions
Interventions
- Bevacizumab Biological
- Electric Field Therapy Procedure
- NovoTTF-200A Device Device
- Quality-of-Life Assessment Procedure
Biological · Procedure · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2016
- Primary completion
- Aug 31, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Jun 26, 2025
2016 – 2026
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| John Wayne Cancer Center at Providence St. John's Health Center | Santa Monica | California | 90404 | Completed |
| Miami Cancer Institute | Miami | Florida | 33176 | Completed |
| Piedmont Healthcare | Atlanta | Georgia | 30309 | Completed |
| Northwestern University | Chicago | Illinois | 60611 | Recruiting |
| Northwestern University- Lake Forest Hospital | Lake Forest | Illinois | 60045 | Active, not recruiting |
| Northwestern Medicine/ Cadence Health - CDH | Winfield | Illinois | 60190 | Recruiting |
| Vidant Medical Center, East Caroling University | Greenville | North Carolina | 27834 | Active, not recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Active, not recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02847559, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 26, 2025 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02847559 live on ClinicalTrials.gov.